
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0539 | -4.9 | 1.1 | 1.29 | 1.035 | 202593 | 1.17388511 | CS |
4 | -0.7839 | -42.8360655738 | 1.83 | 1.88 | 0.9837 | 378663 | 1.29621138 | CS |
12 | -1.1039 | -51.3441860465 | 2.15 | 2.51 | 0.9837 | 301577 | 1.60686798 | CS |
26 | -2.8539 | -73.1769230769 | 3.9 | 4.41 | 0.9837 | 277450 | 2.35435131 | CS |
52 | -9.2839 | -89.8731848984 | 10.33 | 13.59 | 0.9837 | 255851 | 3.75271335 | CS |
156 | -28.9539 | -96.513 | 30 | 55 | 0.9837 | 243421 | 4.2594617 | CS |
260 | -28.9539 | -96.513 | 30 | 55 | 0.9837 | 243421 | 4.2594617 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions